ASRA Announces New Mission Statement to Better Reflect Focus on Patient Care

Jun 12, 2017

The ASRA Board of Directors voted last month to adopt a new mission statement to better reflect the organization’s focus on research, education, and advocacy.

“ASRA has historically focused on research and education,” explained President Asokumar Buvanendran, MD, “but we have increasingly been focusing on regulatory advocacy matters as well, which, along with research and education, are essential to our ultimate goal of helping patients. This focus on advocacy is essential to represent the best interests of our members in providing safe, effective, and high-quality care to their patients.”


The new mission is “advancing the science and practice of regional anesthesiology and pain medicine to improve patient outcomes through research, education, and advocacy.”


ASRA’s two in-person annual meetings and four weekend courses comprise the core of its educational offerings while two grants offering $200,000 in research funding spearhead its efforts to promote quality research in the fields of regional anesthesia and pain medicine. ASRA’s popular bimonthly journal Regional Anesthesia and Pain Medicine provides the latest research and clinical information for providers to stay up to date in their practice. The new mission statement brings in the regulatory advocacy component and points the focus on patient outcomes.

ASRA accomplishes its advocacy efforts by communicating with federal and state regulatory agencies, such as the Centers for Medicare and Medicaid and the Food and Drug Administration, recommending guidelines and standards and providing expert commentary and testimony.

As a testament to its role in the healthcare community, regulatory bodies often invite ASRA to provide feedback. For example, the Centers for Disease Control invited ASRA to be a part of its Adaptation & Dissemination of Outpatient Infection Prevention (ADOPT) project and the Accreditation Council on Graduate Medical Education (ACGME) asked for ASRA’s feedback on its pain medicine graduate medical education guidelines. ASRA also monitors regulations at the state level and regularly provide insight, sharing the latest research findings, such as when threats to coverage of epidural steroid injections occurred in California, Oregon, Washington, Tennessee, and Pennsylvania.

The American Society of Regional Anesthesia and Pain Medicine is a growing professional member organization of more than 4,000 physicians and healthcare providers across the United States and the world. Founded in 1975, ASRA is headquartered in Pittsburgh, PA. For more information, visit www.asra.com.

  


Return to all news